Skip to main content
PMC home page
Science Progress logoLink to Science Progress
. 2009 May 1;92(1):1–38. doi: 10.3184/003685009X440290

Eradicating Malaria

Joel G Breman 1,✉
PMCID: PMC10361125  PMID: 19544698

Abstract

The renewed interest in malaria research and control is based on the intolerable toll this disease takes on young children and pregnant women in Africa and other vulnerable populations; 150 to 300 children die each hour from malaria amounting to 1 to 2 million deaths yearly. Malaria-induced neurologic impairment, anemia, hypoglycemia, and low birth weight imperil normal development and survival. Resistance of Plasmodium falciparum to drugs and Anopheles mosquitoes to insecticides has stimulated discovery and development of artemisinin-based combination treatments (ACTs) and other drugs, long-lasting insecticide-treated bednets (with synthetic pyrethroids) and a search for non-toxic, long-lasting, affordable insecticides for indoor residual spraying (IRS). Malaria vaccine development and testing are progressing rapidly and a recombinant protein (RTS,S/AS02A) directed against the circumsporozoite protein is soon to be in Phase 3 trials. Support for malaria control, research, and advocacy through the Global Fund for HIV/AIDS, Tuberculosis and Malaria, the U.S. President's Malaria Initiative, the Bill & Melinda Gates Foundation, WHO and other organizations is resulting in decreasing morbidity and mortality in many malarious countries. Sustainability of effective programs through training and institution strengthening will be the key to malaria elimination coupled with improved surveillance and targeted research.

Keywords: malaria eradication, disease control, health programs

Full Text

The Full Text of this article is available as a PDF (4.5 MB).

References

  • 1.World Health Organization. (2008) World Malaria Report 2008. Geneva. Switzerland. [Google Scholar]
  • 2.Alilio M.S., Bygbjerg I., and Breman J.G. (2004) Are multilateral malaria research and control programs the most successful? Lessons from the past 100 years in Africa. Am. J. Trop. Med. Hyg., 71(2 Suppl), 268–278. [PubMed] [Google Scholar]
  • 3.World Health Organization. (2008) WHO Global Malaria Control and Elimination: report of a technical review 17–18 January 2008, pp. 1–47. Geneva. Switzerland. [Google Scholar]
  • 4.Breman J.G., Alilio M.S., and White N.J. (2007) Defining and defeating the intolerable burden of malaria: III. Progress and Perspectives: A Summary. Am. J. Trop. Med. Hyg., 77(6 Suppl), vi–xi. [Google Scholar]
  • 5.White N.J., and Breman J.G. (2008) Malaria. In: Fauci A.S., Braunwald E., Kasper D.L., Hauser S.L., Longo D.L., Jameson J.L., and Loscalzo J. (eds.), Harrison's Principles of Internal Medicine, 17th edn, pp. 1280–1294. McGraw Hill Co., New York. [Google Scholar]
  • 6.White N.J., and Breman J.G. (2008) Atlas of blood smears of malaria and babesiosis. In: Kasper D., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (ed.), Harrisons Principles of Internal Medicine, 17th edn, pp. e127. McGraw Hill Co., New York. [Google Scholar]
  • 7.Guerra C.A., Gikandi P.W., Tatern A.J., Noor A.M., Smith D.L., Hay S.I., and Snow R.W. (2008) The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med., 5(2), e38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hay S.I., Guerra C.A., Tatern A.J., Noor A.M., and Snow R.W. (2004) The global distribution and population at risk of malaria: past, present, and future. The lancet Infec. Dis., 4(6), 327–336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., and Hay S.I. (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature, 434, 214–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Price R., Tjitra E., Guerra C.A., Yeung S., White N.J., and Anstey N. (2007). Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg., 77(6 suppl), 79–87. [PMC free article] [PubMed] [Google Scholar]
  • 11.White N.J. (2008). Editorial Commentary: Plasmodium knowlesi: The Fifth Human Malaria Parasite. Clin. Infect. Dis., 46(2), 172–173. [DOI] [PubMed] [Google Scholar]
  • 12.Kelly-Hope L., and McKenzie F.E. (2009) The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malaria J., 8, 19e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Smith T., Maire N., Dietz K., Killeen G.F., Vounatsou P., Molineaux L., and Tanner M. (2006) Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg., 75(2 Suppl), 11–18. [DOI] [PubMed] [Google Scholar]
  • 14.Kiszewski A.E., and Teklehaimanot A. (2004) A review of the clinical and epidemiologic burdens of epidemic malaria. Am. J. Trop. Med. Hyg., 71(2 Suppl), 128–135. [PubMed] [Google Scholar]
  • 15.Bruce Chwatt L.J. (1985) Essential Malariology, pp. 193–200. Wiley Medical, New York. [Google Scholar]
  • 16.Smith D.L., McKenzie F.E., Snow R.W., and Hay S.I. (2007) Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol., 5(3), 531–542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Breman J.G., Alilio M.S., and Mills A. (2004) Conquering the intolerable burden of malaria: II. What's new, what's needed: A summary. Am. J. Trop. Med. Hyg., 71(2 Suppl), 1–15. [PubMed] [Google Scholar]
  • 18.Murphy S.C., and Breman J.G. (2001) Gaps in the childhood malaria burden in Africa: cerebral malaria, neurologic sequelae, anemia, respiratory distress, hypoglycemia and complications of pregnancy. Am. J. Trop. Med. Hyg., 64(Suppl 1–2), 57–67. [DOI] [PubMed] [Google Scholar]
  • 19.Lewallen S., Bronzan R.N., Beare N.A., Harding S.P., Molyneux M.E., and Taylor T.E. (2008) Using malarial retinopathy to improve the classification of children with cerebral malaria. Trans. R. Soc. Trop. Med. Hyg., 102(11), 1089–1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.White V.A., Lewallen S., Beare N.A.V., Molyneux M.E., and Taylor T.E. (2009) Retinal pathology of pediatric cerebral malaria in Malawi. PLoS One, 4(1), e4317. Epub. 2009 Jan 29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Mung'Ala-Odera V., Snow R.W., and Newton C.R.J.C. (2004) The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in Sub-Saharan Africa. Am. J. Trop. Med. Hyg., 71(2 Suppl), 64–70. [PubMed] [Google Scholar]
  • 22.Mung'Ala-Odera V., Meehan R., Njuguna P., Mturi N., Alcock K.J., and Newton C.R.J.C. (2006) Prevalence and risk factors of neurological disability and impairment in children living in rural Kenya. Intl. J. Epid., 35(3), 683–688. [DOI] [PubMed] [Google Scholar]
  • 23.Wellems T.E., Hayton K., and Fairhurst R.M. (2009) Malaria J. Clin. Investigation. In press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bejon P., Berkley J.A., Mwangi T., Ogada E., Mwangi I., Maitland K., Williams T., Scott J.A.G., English M., Lowe B.S., Peshu N., Newton C.R.J.C., and Marsh K. (2007) Defining childhood severe falciparum malaria for intervention studies. PIoS Med., 4(8), 1333–1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gwer S., Newton C.R.J.C., and Berkley J. (2007) Over-diagnosis and comorbidity of severe malaria in African children: A guide for clinicians. Am. J. Trop. Med. Hyg., 77(6 Suppl), 6–13. [PMC free article] [PubMed] [Google Scholar]
  • 26.Steketee R.W., Nahlen B.L., Parise M.E., and Menendez C. (2001) The burden of malaria in pregnancy in malaria-endemic areas. Am. J. Trop. Med. Hyg., 64(1 Suppl), 28–35. [DOI] [PubMed] [Google Scholar]
  • 27.Tuikue Ndam N., and Deloron P. (2008) Towards a vaccine against pregnancy associated malaria. Parasite, 15(3), 515–521. [DOI] [PubMed] [Google Scholar]
  • 28.Breman J.G., and Holloway C.N. (2007) Malaria surveillance counts. Am. J. Trop. Med. Hyg., 77(6 suppl), 36–47. [PubMed] [Google Scholar]
  • 29.Rugemalila J., Ogundahunsi O.A.T., Stedman T.T., and Kilama W.L. (2007) Multilateral Initiative on Malaria: justification, evolution, achievements, challenges, opportunities and future plans. Am. J. Trop. Med. Hyg., 77(6 suppl), 296–302. [PubMed] [Google Scholar]
  • 30.Nantulya F.N., Kengeya-Kayondo J.F, and Ogundahunsi O.A.T. (2007) Research themes and advances in malaria research capacity made by the Multilateral Initiative on Malaria. Am. J. Trop. Med. Hyg., 77(6 suppl), 303–313. [PubMed] [Google Scholar]
  • 31.World Bank. (2005) Millennium development goals. Washington, DC. [Google Scholar]
  • 32.Teklehaimanot A., Singer B., Spielman A., Tozan Y., and Schapira A. (2005) UN Millennium Project. Coming to grips with malaria in the new millennium. Task Force on HIV/AIDS, malaria, TB, and access to essential medicines. Working Group on Malaria, p. 10. [Google Scholar]
  • 33.Breman J.G. (2001) The ears of the hippopotamus: manifestations, determinants and estimates of the malaria burden. Am. J. Trop. Med. Hyg., 64(Suppl 1–2), 1–11. [DOI] [PubMed] [Google Scholar]
  • 34.World Health Organization. (2006) Chemotherapy of malaria. Geneva, Switzerland. [Google Scholar]
  • 35.Sadisivaiah S., Tozan Y., and Breman J. (2007) Dichlorodiphenyltrichloroethane (DDT) for indoor residual spraying in Africa: How can it be used for malaria control? Am. J. Trop. Med. Hyg., 77(6 suppl), 249–263. [PubMed] [Google Scholar]
  • 36.Laxminarayan R., Mills A.J., Breman J.G., Measham A.R., Alleyne G., Claeson M., Jha P., Musgrove P., Chow J., Shahid-Salles S., and Jamison D.T. (2006) Advancement of global health: key messages from the Disease Control Priorities Project. Lancet, 367(9517), 1196–1208. [DOI] [PubMed] [Google Scholar]
  • 37.Bejon P., Lusingu J., Olotu A., Leach A., Lievens M., Vekemans J., Mshamu S., Lang T., Gould J., Dubois M.C., Demoitié M.A., Stallaert J.F., Vansadia P., Carter T., Njuguna P., Awuondo K.O., Malabeja A., Abdul O., Gesase S., Mturi N., Drakeley C.J., Savarese B., Villafana T., Ballou W.R., Cohen J., Riley E.M., Lemnge M.M., Marsh K., and von Seidlein L. (2008) Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N. Engl. J. Med., 359(24), 2521–2532. Epub. 2008 Dec 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Abdulla S., Oberholzer R., Juma O., Kubhoja S., Machera F., Membi C., Omari S., Urassa A., Mshinda H., Jumanne A., Salim N., Shomari M., Aebi T., Schellenberg D.M., Carter T., Villafana T., Demoitié M.A., Dubois M.C., Leach A., Lievens M., Vekemans J., Cohen J., Ballou W.R., and Tanner M. (2008) Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants. N. Engl. J. Med., 359(24), 2533–2544. Epub. 2008 Dec 8. [DOI] [PubMed] [Google Scholar]
  • 39.Sacarlal J., Aide P., Aponte J.J., Renom M., Leach A., Mandomando I., Lievens M., Bassat Q., Lafuente S., Macete E., Vekemans J., Guinovart C., Sigaúque B., Sillman M., Milman J., Dubois M.C., Demoitié M.A., Thonnard J., Menéendez C., Ballou W.R., Cohen J., and Alonso P.L. (2009) Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children. J. Infect. Dis. in press. [DOI] [PubMed] [Google Scholar]
  • 40.Chotivanich K., Sattabongkot J., Udomsangpetch R., Looareesuwan S., Day N.P., Coleman R.E., and White N.J. (2006) Transmission blocking activities of quinine and primaquine. Antimicrob. Agents Chemo., 50(6), 1927–1930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Pukrittayakamee S., Chotivanich K., Chantra A., Clemens R., Looareesuwan S., and White N.J. (2004) Activities of artesunate and primaquine against asexual and sexual stage parasites in falciparum malaria. Antimicrob. Agents Chemo., 48(4), 1329–1334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Slutsker L., and Newman R. (2009) Malaria scale-up progress: is the glass half empty or half full? Lancet, 373(9657), 11–13. [DOI] [PubMed] [Google Scholar]
  • 43.Hay S.I., and Snow R.W. (2006) The Malaria Atlas Project: developing global maps of malaria risk. PLoS Med., 3(12), e473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Guerra C.A., Hay S.I., Lucioparedes L.S., Gikandi P.W., Tatern A.J., Noor A.M., and Snow R.W. (2007) Assembling a global database of malaria parasie prevalence for the Malaria Atlas Project. Malaria J., 6, 17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Guerra C.A., Gikandi P.W., Tatern A.J., Noor A.M., Smith D.L., Hay S.I., and Snow R. W. (2008) The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med., 5(2), e38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bhattarai A., Ali A.S., Kachur S.P., Mårtensson A., Abbas A.K., Khatib R., Al-Mafazy A.W., Ramsan M., Rotllant G., Gerstenmaier J.F., Molteni F., Abdulla S., Montgomery S.M., Kaneko A., and Björkman A. (2007) Impact of artemisinin-based combination theapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med, 4(11), e309. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Science Progress are provided here courtesy of SAGE Publications

RESOURCES